Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis

doi:10.3748/wjg.v25.i39.6025

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12411)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-7) series.

Item

Count

PDF

676

WORD

267

HTML

6628

Figures (1-8)

352

Tables (1-7)

274

Sum=8197

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

615

Download

956

Sum=1571

Publishing Process of This Article

Item

Count

Browse

818

Download

1825

Sum=2643

Oct 21, 2019 (publication date) through Jan 25, 2025

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Oct 21, 2019; 25(39): 6025-6040
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025

Table 3 Subgroup analyses of eradication rates

Comparison	Eradication rate (%)		Heterogeneity		OR	95%CI	P value
Comparison	Allicin group	Control	I² (%)	P value	OR	95%CI	P value
Allicin + PTT vs PTT[15-20] (ITT)	92.47	82.61	0	0.975	2.87	1.65-4.99	< 0.001
Allicin + PTT vs PTT[15-20] (PP)	92.81	82.91	0	0.984	2.66	1.53-4.64	0.001
Allicin-PPI-B-T-C vs PPI-B-T-C[21,22] (ITT/PP)	94.87	85.25	0	0.764	3.19	1.38-7.38	0.007
Allicin-PPI-Am-F vs PPI-Am-F[15,18,20] (ITT/PP)	92.46	81.33	0	0.986	2.38	0.99-5.71	0.053

PPI: Proton pump inhibitor; PTT: Proton pump inhibitor triple therapy; Am: Amoxicillin; F: Furazolidone; C: Clarithromycin; T: Tinidazole; B: Bismuth potassium citrate tablets; ITT: Intent-to-treat analysis; PP: Pre-protocol analysis; OR: Odds ratio; CI: Confidence interval.

Citation: Si XB, Zhang XM, Wang S, Lan Y, Zhang S, Huo LY. Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(39): 6025-6040
URL: https://www.wjgnet.com/1007-9327/full/v25/i39/6025.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i39.6025